Reglagene was awarded 2nd out of 34 entrants from across the nation in the Innovators Pitch Challenge at the #RESI conference! We are proud to be recognized among the top innovators in our field and grateful for the opportunity to showcase our cutting-edge solution for brain cancer.
This achievement is a testament to the hard work and dedication of our team and the innovative spirit that drives our company forward. We are excited to continue pushing the boundaries of what's possible and continue development on a new therapy for patients afflicted with brain cancer.
Thank you to the RESI contest organizers for hosting such a fantastic event and to the pharmaceutical industry representatives and venture capitalists who served as judges. We look forward to continued collaboration and growth in the coming years.